CureVac Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions EUR

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for CureVac N.V. (CVAC) - Annual data in billions EUR
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents0.480.400.500.811.32
Short-Term Investments0.000.000.000.000.00
Cash & Short-Term Investments0.490.400.500.821.32
Accounts Receivable0.010.040.010.020.01
Inventory0.000.020.020.060.01
Other Current Assets0.010.000.010.010.04
Total Current Assets0.530.480.580.941.39
Non-Current Assets
Property, Plant & Equipment (Net)0.240.280.240.200.10
Goodwill0.010.010.010.000.00
Intangible Assets0.010.020.020.010.01
Other Non-Current Assets0.000.000.000.000.01
Total Non-Current Assets0.280.310.280.220.00
Total Assets0.800.790.861.161.51
Current Liabilities
Accounts Payable0.020.050.070.120.02
Accrued Liabilities0.010.010.080.010.02
Deferred Revenue0.000.040.040.060.19
Other Current Liabilities0.020.080.030.040.01
Total Current Liabilities0.070.190.160.360.25
Non-Current Liabilities
Long-Term Debt0.030.040.040.030.03
Deferred Tax Liabilities0.000.000.000.000.00
Other Non-Current Liabilities0.000.000.000.000.00
Total Non-Current Liabilities0.030.080.170.110.00
Total Liabilities0.110.270.330.470.80
Stockholders' Equity
Common Stock0.030.030.020.020.02
Retained Earnings-1.40-1.57-1.31-1.06-0.65
Accumulated Other Comprehensive Income2.072.061.821.731.33
Treasury Stock0.000.000.000.010.00
Shares Outstanding0.220.220.190.190.00
Total Stockholders' Equity0.700.520.530.690.71
Total Liabilities & Equity0.800.790.861.160.00